Form 8-K CV Sciences, Inc. For: Oct 07

Tue, 10 Mar 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260310/26140667.html

Form 8-K CV Sciences, Inc. For: Oct 07

Tue, 10 Mar 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260310/26140667.html

CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth

Tue, 10 Mar 2026 17:00:00 -0400

SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven, science-backed natural ingredients and products, today announced that it has modified its existing outstanding notes to include a conversion feature pursuant to which the outstanding balance of the notes may be converted into common shares of the Company at a fixed conversion price of $0.06 per share.

"We are pleased with the successful completion of a comprehensive debt restructuring, marking a significant

CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth

Tue, 10 Mar 2026 17:00:00 -0400

"We are pleased with the successful completion of a comprehensive debt restructuring, marking a significant

CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness

Thu, 26 Feb 2026 08:30:00 -0400

With 20g of clean protein, 5g of creatine, and LactoSpore® probiotics, Empowr supports everyday strength, mental energy and digestive balance without dairy or added sugar. Simple, functional nutrition for modern living.

SAN DIEGO, CA / ACCESS Newswire / February 26, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven, science-backed natural ingredients and products, today announced the launch of Empowr, a plant-based protein and creatine powder for everyday adults looking to increase daily protein intake for overall wellness.

CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness

Thu, 26 Feb 2026 08:30:00 -0400

SAN DIEGO, CA / ACCESS Newswire / February 26, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven, science-backed natural ingredients and products, today announced the launch of Empowr, a plant-based protein and creatine powder for everyday adults looking to increase daily protein intake for overall wellness.

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

Mon, 22 Dec 2025 19:00:00 -0400

SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today applauds President Trump's recent Executive Order (the "Order") to improve cannabidiol research to better inform patients and doctors. The Order directs agencies within the Department of Health and Human Services to allow Americans to benefit from access to appropriate full-spectrum CBD products based on research methods and models utilizing real-world evidence.

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

Mon, 22 Dec 2025 19:00:00 -0400

SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today applauds President Trump's recent Executive Order (the "Order") to improve cannabidiol research to better inform patients and doctors. The Order directs agencies within the Department of Health and Human Services to allow Americans to benefit from access to appropriate full-spectrum CBD products based on research methods and models utilizing real-world evidence.

CV Sciences (CVSI) Reports Q3 EPS of $0.00

Thu, 13 Nov 2025 18:20:58 -0400

CV Sciences (OTC: CVSI) reported Q3 EPS of $0.00. Revenue for the quarter came in at $3.26 million.

For earnings history and earnings-related data on CV Sciences (CVSI) click here.

Form 10-Q CV Sciences, Inc. For: Sep 30

Thu, 13 Nov 2025 17:19:00 -0400

si-local-file:///var/storage/secattach/20251113/25608815.html

Form 10-Q CV Sciences, Inc. For: Sep 30

Thu, 13 Nov 2025 17:19:00 -0400

si-local-file:///var/storage/secattach/20251113/25608815.html

Form 8-K CV Sciences, Inc. For: Nov 13

Thu, 13 Nov 2025 16:04:00 -0400

si-local-file:///var/storage/secattach/20251113/25607015.html

Form 8-K CV Sciences, Inc. For: Nov 13

Thu, 13 Nov 2025 16:04:00 -0400

si-local-file:///var/storage/secattach/20251113/25607015.html

CV Sciences, Inc. Reports Third Quarter 2025 Financial Results

Thu, 13 Nov 2025 16:00:00 -0400

SAN DIEGO, CA / ACCESS Newswire / November 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended September 30, 2025.

Third Quarter 2025 and Recent Financial and Operating Highlights

Generated revenue of $3.3 million for the third quarter 2025 compared to $3.9 million for the third quarter 2024 and compared to $3.6 million for the second quarter 2025;
Recognized gross margin of

CV Sciences, Inc. Reports Third Quarter 2025 Financial Results

Thu, 13 Nov 2025 16:00:00 -0400

Third Quarter 2025 and Recent Financial and Operating Highlights

Generated revenue of $3.3 million for the third quarter 2025 compared to $3.9 million for the third quarter 2024 and compared to $3.6 million for the second quarter 2025;
Recognized gross margin of

CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025

Mon, 10 Nov 2025 18:15:00 -0400

SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 10, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the third quarter ended September 30, 2025, after the stock market closes on Thursday, November 13, 2025. The Company will hold a conference call with the investment community at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) that same day.

The webcast

CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025

Mon, 10 Nov 2025 18:15:00 -0400

The webcast

Form 8-K CV Sciences, Inc. For: Oct 07

Fri, 10 Oct 2025 17:05:00 -0400

si-local-file:///var/storage/secattach/20251010/25445551.html

Form 8-K CV Sciences, Inc. For: Oct 07

Fri, 10 Oct 2025 17:05:00 -0400

si-local-file:///var/storage/secattach/20251010/25445551.html

Form 8-K CV Sciences, Inc. For: Feb 12

Thu, 18 Sep 2025 16:24:00 -0400

si-local-file:///var/storage/secattach/20250918/25351753.html

Form 8-K CV Sciences, Inc. For: Feb 12

Thu, 18 Sep 2025 16:24:00 -0400

si-local-file:///var/storage/secattach/20250918/25351753.html

CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus

Tue, 26 Aug 2025 21:00:00 -0400

Ignite delivers a powerful blend of proven botanicals along with our award-winning CBD, designed to help men stay strong, sharp, and ready-at work, in the gym, and beyond.

SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 26, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven, science-backed natural ingredients and products, today announced the launch of Ignite, a performance formula designed for men aged 35+ seeking natural support for vitality, recovery, and focus. Ignite combines clinically respected botanicals with full

CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus

Tue, 26 Aug 2025 21:00:00 -0400

Ignite delivers a powerful blend of proven botanicals along with our award-winning CBD, designed to help men stay strong, sharp, and ready-at work, in the gym, and beyond.

CV Sciences (CVSI) Reports Q2 EPS of $0.00

Wed, 13 Aug 2025 18:29:26 -0400

CV Sciences (OTC: CVSI) reported Q2 EPS of $0.00, versus $0.00 reported last year. Revenue for the quarter came in at $3.62 million.

For earnings history and earnings-related data on CV Sciences (CVSI) click here.

Form 10-Q CV Sciences, Inc. For: Jun 30

Wed, 13 Aug 2025 17:23:00 -0400

si-local-file:///var/storage/secattach/20250813/25197944.html

StreetInsider.com News Articles

Form 8-K CV Sciences, Inc. For: Oct 07

Form 8-K CV Sciences, Inc. For: Oct 07

CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth

CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth

CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness

CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

CV Sciences (CVSI) Reports Q3 EPS of $0.00

Form 10-Q CV Sciences, Inc. For: Sep 30

Form 10-Q CV Sciences, Inc. For: Sep 30

Form 8-K CV Sciences, Inc. For: Nov 13

Form 8-K CV Sciences, Inc. For: Nov 13

CV Sciences, Inc. Reports Third Quarter 2025 Financial Results

CV Sciences, Inc. Reports Third Quarter 2025 Financial Results

CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025

CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025

Form 8-K CV Sciences, Inc. For: Oct 07

Form 8-K CV Sciences, Inc. For: Oct 07

Form 8-K CV Sciences, Inc. For: Feb 12

Form 8-K CV Sciences, Inc. For: Feb 12

CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus

CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus

CV Sciences (CVSI) Reports Q2 EPS of $0.00

Form 10-Q CV Sciences, Inc. For: Jun 30